TransUnion TRU Q1 2026 Earnings EPS Tops Estimates by 65 Amid Resilient Demand Special Edition Trump Passport Sparks Political Controversy Potential Legal Challenges Ahead Market Wrap Sensex Slips 1 From Intraday High Nifty Closes Near 23650 Amid Rising Bond Yields Oura HealthTracking Smart Ring Pioneer Files Confidentially for IPO Dodgers Catcher Will Smith Addresses Injury Concerns After Early Exit Quantum Computing Stocks Rally as US Government Plans 2 Billion in Grants and Equity Stakes Goldman Sachs Maintains Bullish Outlook on LATAM Airlines Raises Price Target Trump Signals Potential Decision on Iran Nuclear Deal by Sunday Geopolitical Tensions Could Impact Oil Markets EEOC May End DecadesOld Demographic Data Collection Requirement Reshaping Workplace Discrimination Enforcement Chinas Humanoid Robot Ambitions Pose Growing Competition Musk Warns BTC Development Corp Unit BDCIU Q1 2026 Earnings Positive EPS Reported Amid Limited Disclosures Upstream Bio UPB Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Edges Lower GETY Q1 2026 Earnings EPS Falls Sharply Below Consensus Stock Slips Nike NKE Q1 2026 Earnings EPS Surges Past Estimates with 2289 Beat CNTA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment Taoping Inc TAOP Slides 419 as Shares Test Key Support Near 125 Apple Hospitality REIT APLE Faces Resistance Stock Slightly Lower on Modest Volume KALA BIO Shares Slide Over 6 Amid Light Trading and Sector Pressure Meiwu Technology WNW Slips 39 as Support Levels Come into Focus London Stock Exchange Group Reports Income Growth Driven by Tradeweb Platform Performance Post Office Horizon Scandal Inquiry Faces FiveYear Delay Without Extra Funding Police Warn Global Leaders Closely Monitor Potential TrumpXi Summit Amid Trade Uncertainty Trumps Iran Deal Faces Republican Skepticism Amid Asset Unfreeze Oil Prices Edge Higher as USIran Talks Show Limited Progress European Commissions EV Push Contradicted by Own Fleets Strasbourg Range Issue Secure Waste Shareholders Approve Acquisition by GFL Environmental CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses